The PRODIGY Trial
PRODIGY (PRediction of Opioid‐induced respiratory Depression In patients monitored by capnoGraphY) is a prospective, multi‐center, international cohort study to assess the potential for respiratory compromise (RC) risk assessment in patients receiving opioids on the hospital general care floor also examining the value of continuous capnography and oximetry monitoring.
-
55:27Watch VideoInterviews on Respiratory Compromise
Thought leaders discuss why they believe respiratory compromise is an important safety issue needing better solutions.
-
2:28Watch VideoVideo: Evidence Summary of PRODIGY Study
-
Download NowThe PRODIGY Study at a Glance
-
BACK TO RESPIRATORY COMPROMISE RESOURCES
VIEW ALL -
Learn More
Dr. Khanna PRODIGY Podcast
Dr. Ludwig Lin interviews Dr. Ashish Khanna on the preliminary results of the PRODIGY study, awarded a Star Research Presentation at the SCCM conference.
-
Download NowTalking Points on the PRODIGY Study
-
![Respiratory Compromise: First, Do No Harm [Learn More]](https://content.cdntwrk.com/files/aT0xMDczNzA5JnA9MCZ2ZXJzaW9uPTEmY21kPXYmc2lnPWFkZWQ1ZWU0ZDViMDk0NjBkNmVlZGFmZjQ2YThjM2Yz/-w-320.jpg)
Download NowRespiratory Compromise: First, Do No Harm [Learn More]
-
2:25Watch VideoVideo: Evidence Summary PRODIGY Seeking Answers
-
Download NowCSM Khanna Seeking Answers from PRODIGY Clinical Summary
-
Download NowPresentation: An Overview of the PRODIGY Study
-
Download NowRespiratory Compromise PRODIGY FAQ
-
Loading More...
